Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Rev Cancer. 2001 Dec;1(3):222-31.

To cycle or not to cycle: a critical decision in cancer.

Author information

1
Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain. marcos.malumbres@cnio.es

Abstract

Tumour cells undergo uncontrolled proliferation, yet tumours most often originate from adult tissues, in which most cells are quiescent. So, the proliferative advantage of tumour cells arises from their ability to bypass quiescence. This can be due to increased mitogenic signalling and/or alterations that lower the threshold required for cell-cycle commitment. Understanding the molecular mechanisms that underlie this commitment should provide important insights into how normal cells become tumorigenic and how new anticancer strategies can be devised.

PMID:
11902577
DOI:
10.1038/35106065
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center